Nasdaq:US$17.93 (+1.56) | HKEX:HK$27.56 (-0.44) | AIM:£2.63 (+0.03)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing